Remove 2008 Remove Doctors Remove Research
article thumbnail

Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD

Alta Sciences

Addressing New Challenges in Human Abuse Potential Research The CCALC has held face-to-face meetings in collaboration with industry, academia, and the FDA once every two to three years since inception, and has provided much of the industry perspective on the practical challenges and solutions to assessing abuse and dependence potential.

article thumbnail

Gianluca Pirozzi, MD, PhD, Celebrated for Dedication to the Field of Immunology and Rare Disease Research

The Pharma Data

Dr. Pirozzi received a Doctorate of Medicine from Università Campus Bio-Medico di Roma in Italy, a Doctorate of Philosophy in Immunology from Sapienza Università di Roma in Italy, a Post-Doctorate degree in Immunology from the Institut Pasteur in Paris, France, and business training at the London Business School, UK.

Disease 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dr. Lolettima O. Johnson Celebrated for Dedication to the Field of Medicine

The Pharma Data

Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. Doctor Johnson aspires to incorporate the latest technologies available in healthcare to care for her patients. Subsequently, she decided to pursue a higher education in pharmacology following her high school graduation.

article thumbnail

AHA News: Hospice Candidate at 2, She’s Now 13 and Thriving

The Pharma Data

” That was the term the doctors used six months after a third surgery to correct a heart defect that left her struggling to breathe while her lungs continued to fill with fluid. A doctor suggested hospice. Several doctors came in to evaluate what they were seeing. She had her second open-heart surgery in February 2008.

Doctors 52
article thumbnail

MS Has Mixed Impact on Patients’ Cancer Risk: Study

The Pharma Data

The answer may depend on the type of cancer, new research shows. But there was good news, too: Their risk of breast and colon cancer is no higher than for people who don’t have MS, according to the Canadian researchers. Why MS patients are prone to bladder cancer isn’t clear.

Doctors 52
article thumbnail

Rap Music Is Putting Mental Health in the Spotlight

The Pharma Data

. “I think anyone who’s been a fan of rap music across the last two decades — myself included — had a feeling this was happening,” said study author Alex Kresovich, a doctoral fellow in the Hussman School of Journalism and Media at the University of North Carolina at Chapel Hill.

Doctors 52
article thumbnail

Women in Stem with Vicky Marsh Durban

Drug Target Review

Following on from my Bachelors’ degree research project, I stayed at Cardiff University to do my PhD and that’s what got me into cancer research. You can take it anywhere—scientific research is the same in every lab around the world. I would say that the opportunity to travel is a real plus for careers in STEM.

Doctors 59